Objective: Trans-catheter (TC) pulmonary valve replacement (PVR) has become common practice for patients with right ventricular outflow tract obstruction (RVOTO) and/or pulmonic insufficiency (PI). Our aim was to compare PVR and right ventricular (RV) function of patients who received TC vs surgical PVR.
dilation and dysfunction, and sometimes associated left ventricular diastolic and systolic dysfunction. These are well-known risk factors for arrhythmias, sudden death, and heart failure. [1] [2] [3] [4] years, TC PVR has become common practice for patients with RVOTO and/or PI as a less invasive alternative to traditional surgical PVR. The
Melody valve, as the first FDA approved TC PVR, has been studied most extensively. It has been shown to be safe and effective with excellent short-and intermediate-term outcomes. [5] [6] [7] [8] Some cardiologists therefore advocate for an earlier PVR when using a TC valve compared to surgical PVR. 9 To date, there is little data comparing outcomes in patients who receive TC vs surgical PVR. The aim of this study was to compare PVR and RV function of patients who received TC Melody valves to those who underwent surgical PVR before, shortly following PVR, and at the time of last follow-up.
| M ETH OD S
This is a retrospective cohort study of congenital heart disease patients who underwent Melody valve (group TC) or surgical (group S) PVR at Yale New Haven Children's hospital between January 2011 and June
2014.
Exclusion criteria were lack of follow-up echocardiogram >180 days following PVR. We recorded patients' original cardiac anatomy, prior surgeries, and clinical characteristics such as age, age at valve replacement, and body surface area. Right ventricular outflow tract (RVOT) physiology prior to PVR was categorized as follows: (1) at least moderate RVOTO, at most mild PI, (2) moderate or severe PI, at most mild RVOTO, (3) at least moderate RVOTO and moderate or severe PI.
Echocardiograms from three different time points (last study prior to PVR, first study after PVR, and last available follow-up) were analyzed (see 2.1).
PVR dysfunction as the primary outcome was defined as the presence of at least moderate graft PS and/or PI.
| Echocardiograms
Echocardiograms were performed by experienced pediatric echocardiographers according to the pediatric guidelines of the American Society of Echocardiography. 10 There was no significant difference between groups in age, gender, body surface area, or length of follow-up (Table 1 ). In the TC group, the most frequent underlying cardiac diagnoses were tetralogy of Fallot The RVOT physiology at baseline differed between the two groups as well, in that the majority of group S had PI without significant RVOT obstruction, while the picture was rather mixed in group TC (Tables 1   and 2 ).
| Right ventricular outflow tract physiology
At the initial postprocedural echocardiogram group, TC had a slightly higher peak gradient across the RVOT, but there was no significant PI in either group (Table 2) . At most recent follow-up, however, group TC had stable valve function without significant insufficiency or stenosis 
| Groups TC vs S -age effect on PVR function
For patients <17 years of age at the time of PVR, the TC group had significantly better valve function in follow-up compared to group S (Table 3) . For patients age 17 or more, there was no significant difference between groups TC and S. In a multiple logistic regression model, length of follow-up was not significantly associated with higher risk for valve dysfunction in either group.
| Right heart structure and function
Lastly, we evaluated the effect of TC vs S PVR on right heart size and function (Table 4) . Both groups had a significant decrease in right atrial and RV size following PVR, whereas RVOT dimensions and RV free wall thickness showed no significant change. RV systolic function assessed by quantitative echocardiographic measures remained stable following TC PVR. However, in group S there was a significant decline in RV function immediately following PVR ( Table 4 ) that only partially recovered at the time of last follow-up.
| D I SCUSSION
This is the first published study on patients with TC vs surgical PVR that compares both PVR and right heart function in follow-up. We 
| Indications for PVR
Timing of PVR in pediatric patients continues to be controversial given the associated added risk of additional cardiac surgical procedures in a life time. Prior studies have suggested that an aggressive approach to PVR (end diastolic volume <150 ml/m 2 ) leads to normalization of RV volumes, and improvement in biventricular function, and submaximal exercise capacity. 13 The authors showed that normalization of ventilatory response to carbon dioxide production, a parameter that has been shown to predict outcome in TOF, is most likely to occur when surgery is performed below age <17.5 years.
13,14
| Data on surgical PVR
Data on surgical PVR durability, however, varies widely from 50% to 96% at 10 years. [15] [16] [17] A large study of 505 patients pediatric and young adult patients has shown that homografts may be superior to xenografts with a mean time to reoperation of 16 compared to 10.3 years. 18 The effect of age on PVR longevity has also been analyzed by several groups, suggesting that younger age at PVR predicts shorter graft longevity. [19] [20] [21] [22] Earlier PVR dysfunction appears particularly noticeable in children <13-18 years of age. 17, 20, 21 These reports are consistent with our data on surgical PVR showing that children <17
years of age at the time of PVR were at high risk for early valve dysfunction. Due to the rapid valve degeneration in some of our young patients with surgical PVR, we believe that somatic growth alone cannot explain this phenomenon. We speculate that other, for example, immunologic factors may play a role. 23, 24 Whatever the cause of early valve degeneration in children and adolescents is, we have to acknowledge that there is a fine balance between preserving RV function and limiting the number of surgeries in a lifetime.
| Data on TC PVR
Over the last decade TC PVR has been used increasingly. It has been shown in a single center study of 51 patients (including 26 younger than 16 years of age) that younger age at the time of TC PVR is associated with incremental improvements in RV size, function and maximum oxygen consumption. 9 Procedural and mid-term results with up to seven years follow-up have been excellent. 8, 9, 25 As experience with TC PVR is growing, some centers-including ours-have been successfully been placing TC PVR in native outflow tracts as well. 26 TC TPV replacement can also be performed in children <30 kg with good procedural and early hemodynamic results in the majority of patients. 27 In small children (15 kg) who are not suitable for a TC approach, the Melody valve has been placed via the perventricular route with good mid-term results (personal experience).
Given the previously published positive effect of younger age at the time of TC PVR on RV size, function and maximum oxygen consumption 9 and our data showing that TC PVR longevity is excellent and comparable to adult patients, we suggest that TC PVR should in fact be considered first choice in children and adolescents, including select patients with at "native" RVOT or a transannular patch.
| Right heart remodeling following PVR
Right atrial and right ventricular size decreased in both groups following PVR. However, there was a differential effect on quantitative parameters of RV systolic function-while function was preserved in group TC, there was a transient decline in group S that only partially recovered in follow-up. This effect is likely related to cardiopulmonary bypass (CPB) as a decline in longitudinal right ventricular function has been described previously. 28 While our findings should be validated in a larger cohort and validated by MRI, they are further evidence supporting TC PVR when feasible.
| Limitations
This study's main limitation is that it is a retrospective observational echocardiography based study without concomitant MRI imaging. As the duration of follow-up is limited, we plan to revisit the data in a few years to assess long-term results.
| Conclusion
We conclude that TC Melody valve placement in patients <17 years of age is associated with better pulmonary valve function in mid-term follow-up when compared to surgical PVR. In adult patients, however, there was a low incidence of PVR dysfunction in both groups. The transient decline in RV function seen following surgical PVR was not observed following TC PVR. We propose that TC Melody PVR should therefore be the first choice for children and adolescents who are considered for PVR. This should include patients who have undergone a transannular patch or who have a "native" outflow if their RVOT is considered favorable on a preprocedural MRI.
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